01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
Employers interviewing women of child-bearing age may be tempted to ask about plans for having a bab...
Read More >
According to OPTIS Partners’ latest quarterly report, following a slowdown in the second quarter of...
Read More >
In a favorable opinion for employers, the California Court of Appeal for the Second District conclud...
Read More >
By March 2, 2020, employers must submit their Form 300A information through OSHA’s Injury Tracking ...
Read More >
It was another fairly quiet week at the General Assembly. Several House committees advanced bills th...
Read More >
The most impactful legislation affecting retirement accounts in decades became effective on January ...
Read More >